Literature DB >> 25680625

Studies of retroviral infection in humanized mice.

Matthew D Marsden1, Jerome A Zack2.   

Abstract

Many important aspects of human retroviral infections cannot be fully evaluated using only in vitro systems or unmodified animal models. An alternative approach involves the use of humanized mice, which consist of immunodeficient mice that have been transplanted with human cells and/or tissues. Certain humanized mouse models can support robust infection with human retroviruses including different strains of human immunodeficiency virus (HIV) and human T cell leukemia virus (HTLV). These models have provided wide-ranging insights into retroviral biology, including detailed information on primary infection, in vivo replication and pathogenesis, latent/persistent reservoir formation, and novel therapeutic interventions. Here we describe the humanized mouse models that are most commonly utilized to study retroviral infections, and outline some of the important discoveries that these models have produced during several decades of intensive research.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Animal models; Gene therapy; HIV; HTLV; Humanized mice; Latency; Pathogenesis; SCID mouse

Mesh:

Year:  2015        PMID: 25680625      PMCID: PMC4424058          DOI: 10.1016/j.virol.2015.01.017

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  167 in total

1.  Multiple blocks to human immunodeficiency virus type 1 replication in rodent cells.

Authors:  P D Bieniasz; B R Cullen
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Development of a human adaptive immune system in cord blood cell-transplanted mice.

Authors:  Elisabetta Traggiai; Laurie Chicha; Luca Mazzucchelli; Lucio Bronz; Jean-Claude Piffaretti; Antonio Lanzavecchia; Markus G Manz
Journal:  Science       Date:  2004-04-02       Impact factor: 47.728

Review 3.  The effects of HIV on hematopoiesis.

Authors:  V Calenda; J C Chermann
Journal:  Eur J Haematol       Date:  1992-04       Impact factor: 2.997

4.  Enhanced human CD4+ T cell engraftment in beta2-microglobulin-deficient NOD-scid mice.

Authors:  S W Christianson; D L Greiner; R A Hesselton; J H Leif; E J Wagar; I B Schweitzer; T V Rajan; B Gott; D C Roopenian; L D Shultz
Journal:  J Immunol       Date:  1997-04-15       Impact factor: 5.422

5.  Interleukin-7 induces expression of latent human immunodeficiency virus type 1 with minimal effects on T-cell phenotype.

Authors:  Deirdre D Scripture-Adams; David G Brooks; Yael D Korin; Jerome A Zack
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

Review 6.  Historical perspective of foamy virus epidemiology and infection.

Authors:  C D Meiering; M L Linial
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

Review 7.  Current advances in humanized mouse models.

Authors:  Ryoji Ito; Takeshi Takahashi; Ikumi Katano; Mamoru Ito
Journal:  Cell Mol Immunol       Date:  2012-02-13       Impact factor: 11.530

8.  T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice.

Authors:  Priti Kumar; Hong-Seok Ban; Sang-Soo Kim; Haoquan Wu; Todd Pearson; Dale L Greiner; Amale Laouar; Jiahong Yao; Viraga Haridas; Katsuyoshi Habiro; Yong-Guang Yang; Ji-Hoon Jeong; Kuen-Yong Lee; Yong-Hee Kim; Sung Wan Kim; Matthias Peipp; Georg H Fey; N Manjunath; Leonard D Shultz; Sang-Kyung Lee; Premlata Shankar
Journal:  Cell       Date:  2008-08-07       Impact factor: 41.582

9.  Evolution of the HIV-1 env gene in the Rag2-/- gammaC-/- humanized mouse model.

Authors:  William L Ince; Liguo Zhang; Qi Jiang; Kathryn Arrildt; Lishan Su; Ronald Swanstrom
Journal:  J Virol       Date:  2009-12-30       Impact factor: 5.103

10.  Generation of HIV latency in humanized BLT mice.

Authors:  Paul W Denton; Rikke Olesen; Shailesh K Choudhary; Nancy M Archin; Angela Wahl; Michael D Swanson; Morgan Chateau; Tomonori Nochi; John F Krisko; Rae Ann Spagnuolo; David M Margolis; J Victor Garcia
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

View more
  23 in total

Review 1.  Of mice and monkeys: can animal models be utilized to study neurological consequences of pediatric HIV-1 infection?

Authors:  Heather Carryl; Melanie Swang; Jerome Lawrence; Kimberly Curtis; Herman Kamboj; Koen K A Van Rompay; Kristina De Paris; Mark W Burke
Journal:  ACS Chem Neurosci       Date:  2015-06-19       Impact factor: 4.418

2.  Propagating Humanized BLT Mice for the Study of Human Immunology and Immunotherapy.

Authors:  Drake J Smith; Levina J Lin; Heesung Moon; Alexander T Pham; Xi Wang; Siyuan Liu; Sunjong Ji; Valerie Rezek; Saki Shimizu; Marlene Ruiz; Jennifer Lam; Deanna M Janzen; Sanaz Memarzadeh; Donald B Kohn; Jerome A Zack; Scott G Kitchen; Dong Sung An; Lili Yang
Journal:  Stem Cells Dev       Date:  2016-10-18       Impact factor: 3.272

Review 3.  HIV-1 Eradication: Early Trials (and Tribulations).

Authors:  Adam M Spivak; Vicente Planelles
Journal:  Trends Mol Med       Date:  2015-12-12       Impact factor: 11.951

Review 4.  HIV-associated neurocognitive disorder--pathogenesis and prospects for treatment.

Authors:  Deanna Saylor; Alex M Dickens; Ned Sacktor; Norman Haughey; Barbara Slusher; Mikhail Pletnikov; Joseph L Mankowski; Amanda Brown; David J Volsky; Justin C McArthur
Journal:  Nat Rev Neurol       Date:  2016-03-11       Impact factor: 42.937

Review 5.  Humanized Mouse Models for Human Immunodeficiency Virus Infection.

Authors:  Matthew D Marsden; Jerome A Zack
Journal:  Annu Rev Virol       Date:  2017-07-26       Impact factor: 10.431

6.  μ-Lat: A mouse model to evaluate human immunodeficiency virus eradication strategies.

Authors:  Hannah S Sperber; Padma Priya Togarrati; Kyle A Raymond; Mohamed S Bouzidi; Renata Gilfanova; Alan G Gutierrez; Marcus O Muench; Satish K Pillai
Journal:  FASEB J       Date:  2020-09-09       Impact factor: 5.191

7.  A participant-derived xenograft model of HIV enables long-term evaluation of autologous immunotherapies.

Authors:  Chase D McCann; Christiaan H van Dorp; Ali Danesh; Adam R Ward; Thomas R Dilling; Talia M Mota; Elizabeth Zale; Eva M Stevenson; Shabnum Patel; Chanson J Brumme; Winnie Dong; Douglas S Jones; Thomas L Andresen; Bruce D Walker; Zabrina L Brumme; Catherine M Bollard; Alan S Perelson; Darrell J Irvine; R Brad Jones
Journal:  J Exp Med       Date:  2021-05-14       Impact factor: 14.307

Review 8.  Perspectives on Non-BLT Humanized Mouse Models for Studying HIV Pathogenesis and Therapy.

Authors:  Kazutaka Terahara; Ryutaro Iwabuchi; Yasuko Tsunetsugu-Yokota
Journal:  Viruses       Date:  2021-04-28       Impact factor: 5.048

Review 9.  Translating Treg Therapy in Humanized Mice.

Authors:  Susanne A Hahn; Iris Bellinghausen; Bettina Trinschek; Christian Becker
Journal:  Front Immunol       Date:  2015-12-14       Impact factor: 7.561

10.  Synthetic Ingenols Maximize Protein Kinase C-Induced HIV-1 Latency Reversal.

Authors:  Adam M Spivak; Racheal A Nell; Mark Petersen; Laura Martins; Paul Sebahar; Ryan E Looper; Vicente Planelles
Journal:  Antimicrob Agents Chemother       Date:  2018-10-24       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.